Submission Details
| 510(k) Number | K014233 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 26, 2001 |
| Decision Date | January 24, 2002 |
| Days to Decision | 29 days |
| Submission Type | Special |
| Review Panel | Microbiology (MI) |
| Summary | Statement |
K014233 is an FDA 510(k) clearance for the CAPTIAM SYPHILIS-G ASSAY, a Enzyme Linked Immunoabsorption Assay, Treponema Pallidum (Class II — Special Controls, product code LIP), submitted by Trinity Biotech, Plc (Co. Wicklow, IE). The FDA issued a Cleared decision on January 24, 2002, 29 days after receiving the submission on December 26, 2001. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3830.
| 510(k) Number | K014233 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 26, 2001 |
| Decision Date | January 24, 2002 |
| Days to Decision | 29 days |
| Submission Type | Special |
| Review Panel | Microbiology (MI) |
| Summary | Statement |
| Product Code | LIP — Enzyme Linked Immunoabsorption Assay, Treponema Pallidum |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3830 |